TS-014812 — An improved de
livery mechanism has been developed for hydrophobic drugs such as camptot
hecin which will increase c
hemot
herapeutic efficacy.
Many cancer therapeutics exhibit extremely toxic side effects or have limited efficacy due to low bio-availability. Existing drug delivery technologies can add excessive mass to the therapeutic, grossly expanding the dosage necessary for response. Camptothecin (CPT) is a naturally occurring compou…